$LEVI

Singh Harmit J sold $2.4M of LEVI

Singh Harmit J (EVP & Chief Fin. & Growth Ofc.) sold 98,144 shares of LEVI STRAUSS & CO (LEVI) at $24.22 ($2.38M total) on 2026-07-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Singh Harmit J
Published Jul 25, 2026, 1:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 25, 2026, 2:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Neutral
high confidence
Mentioned
$LEVI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVINeutralLow
01

Why it matters

This provides incremental transparency on insider activity but does not introduce new guidance, financial results, or regulatory developments for LEVI.

02

Market read

Traders may monitor insider selling trends, but the planned nature of the sale suggests limited fundamental impact.

03

What to watch

The article does not state total compensation, tax context, or whether sales were part of a broader scheduled cadence, which can reduce interpretability of the signal.

Relevance 5/10Novelty 3/10Timing: Filed 2026-07-24 after the sale on 2026-07-23

Background

The article is an SEC Form 4 insider transaction for LEVI, reporting an open-market sale by an EVP under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$LEVINeutralHigh confidence
Context

LEVI insider Form 4 shows EVP Harmit J. Singh sold 98,144 shares at $24.22 on 2026-07-23 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only and typically muted for planned 10b5-1 sales.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly marked as pre-arranged under Rule 10b5-1, and provides no new company fundamentals beyond the sale details.

Market effects

No sector read-across; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with private views on valuation or liquidity needs, so some traders may still treat it as a mild negative signal.

Key entities

  • LEVI Strauss & Co

    Company whose insider transaction is disclosed on Form 4.

  • Harmit J. Singh

    EVP and Chief Financial and Growth Officer who sold shares.

  • Rule 10b5-1 plan

    Pre-arranged plan indicating the sale was scheduled in advance.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVIHighAI 8/10

Levi's CEO admits the company missed the biggest jeans trend of the year

Levi Strauss & Co. (LEVI) CEO Michelle Gass admitted the company missed the U.S. shift to low-rise jeans during the back-to-school season, impacting its direct-to-consumer sales. Despite a 4% revenue increase to $1.6 billion in Q3, shares fell nearly 5%. Levi's has since refocused marketing on low-rise styles and expects full-year revenue growth of about 6%.

$LEVIMed

Levi Strauss CEO Sounds Alarm on Growing Competition in Denim Market

Levi Strauss reported mixed results: European revenue rose 4-5%, Asia saw 5-10% growth, and Signature brand revenue jumped 13%. The company raised its adjusted earnings forecast to $1.54-$1.56 per share but lowered its revenue growth outlook to ~7%. CEO Michelle Gass noted increased competition in the denim market, emphasizing the need for innovation to maintain market share.

$LEVIMed

BNP Paribas Exane raises Levi Strauss price target to $35

BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.